Clarke's Analysis of Drugs and Poisons

Whitepaper

Challenges in Novel Psychoactive Substance Forensic Toxicology

“Rapidly emerging and evolving synthetic drugs, such as synthetic cannabinoids and fentanyl analogs (collectively considered novel psychoactive substances, or NPS), as well as the increased use of prescription drugs, has significantly compromised the ability of forensic toxicology laboratories to support criminal and civil investigations in a timely fashion.”

SOFTToxTalk2017


COMPLETE THE FORM TO DOWNLOAD THE WHITEPAPER

We collect and process data in accordance with our Privacy Policy. By submitting this form you agree to receive marketing emails from Pharmaceutical Press.

This statement, made in 2017 by the Society of Forensic Toxicology’s then President, Dr. Bruce Goldberger, is echoed in sentiment throughout the toxicology community in conferences, at society meet-ups, and in recent reports that outline the difficulties toxicologists face today.


In this paper, we focus on key issues centric to these challenges, including:

  • Insufficient availability of certified reference materials
  • Collation, sharing and interpretation of data
  • The absence of standardised regulatory guidelines


Simply fill in the form opposite to download our paper.


© 2019 Royal Pharmaceutical Society